Thomas C. King
Chief Tech/Sci/R&D Officer at IMMUNOVIA AB
Profile
Thomas C.
King is currently working as a Medical Director at Immunovia AB and Immunovia, Inc. He is also an Associate Professor at Rutgers School of Health Professions.
In the past, he worked as a Senior Director-Molecular Pathology at Millennium Pharmaceuticals, Inc., Director at Medpace, Inc., Medical Director-Pathology & Laboratory Medicine at University Medical Group, Inc., Independent Director at Medpace Holdings, Inc., Partner & Medical Director-Pathology at University Pathologists LLC, and Chief-Pathology & Laboratory Medicine at Saint Vincent Hospital LLC.
He completed his undergraduate, graduate, and doctorate degrees from Washington University in St. Louis.
Thomas C. King active positions
Companies | Position | Start |
---|---|---|
IMMUNOVIA AB | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Immunovia, Inc. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Rutgers School of Health Professions | Corporate Officer/Principal | - |
Former positions of Thomas C. King
Companies | Position | End |
---|---|---|
MEDPACE HOLDINGS, INC. | Director/Board Member | 2022-12-30 |
Saint Vincent Hospital LLC
Saint Vincent Hospital LLC Hospital/Nursing ManagementHealth Services Saint Vincent Hospital LLC engages in healthcare services. Its medical services include behavioral health, cancer care, digestive disorders, imaging services, maternity, and orthopedics. The company was founded in 1893 and is headquartered in Worcester, MA. | Corporate Officer/Principal | 2016-12-31 |
University Pathologists LLC /US/
University Pathologists LLC /US/ Medical/Nursing ServicesHealth Services University Pathologists LLC is a private company based in Warwick, RI. The company provides pathology services. | Corporate Officer/Principal | 2012-12-31 |
University Medical Group, Inc. | Corporate Officer/Principal | 2007-12-31 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2002-12-31 |
Training of Thomas C. King
Washington University in St. Louis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MEDPACE HOLDINGS, INC. | Commercial Services |
IMMUNOVIA AB | Health Technology |
Private companies | 7 |
---|---|
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Commercial Services |
Immunovia, Inc. | |
Rutgers School of Health Professions | |
Saint Vincent Hospital LLC
Saint Vincent Hospital LLC Hospital/Nursing ManagementHealth Services Saint Vincent Hospital LLC engages in healthcare services. Its medical services include behavioral health, cancer care, digestive disorders, imaging services, maternity, and orthopedics. The company was founded in 1893 and is headquartered in Worcester, MA. | Health Services |
University Pathologists LLC /US/
University Pathologists LLC /US/ Medical/Nursing ServicesHealth Services University Pathologists LLC is a private company based in Warwick, RI. The company provides pathology services. | Health Services |
University Medical Group, Inc. | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Thomas C. King